R.A. Session II's Net Worth

$14.6 Million

Who is R.A. Session II?

R.A. Session II has an estimated net worth of $14.6 Million. This is based on reported shares across multiple companies, which include Taysha Gene Therapies, Inc., AveXis, Inc., and Chardan Healthcare Acquisition 2 Corp..

SEC CIK

R.A. Session II's CIK is 0001701846

Past Insider Trading and Trends

2021 was R.A. Session II's most active year for acquiring shares with 3 total transactions. R.A. Session II's most active month to acquire stocks was the month of February. 2023 was R.A. Session II's most active year for disposing of shares, totalling 7 transactions. R.A. Session II's most active month to dispose stocks was the month of April. 2021 saw R.A. Session II paying a total of $529,102.40 for 242,218 shares, this is the most they've acquired in one year. In 2023 R.A. Session II cashed out on 748,595 shares for a total of $388,733.84, their largest year based on trade value.